XIENCE V Everolimus Eluting Coronary Stent System (EECSS) China: Post-Approval, Single-Arm Study

NCT01249027 · clinicaltrials.gov ↗

COMPLETED

Status

2605

Enrollment

INDUSTRY

Sponsor class

Conditions

Angioplasty
Chronic Coronary Occlusion
Stent Thrombosis
Vascular Disease
Myocardial Ischemia
Coronary Artery Stenosis
Coronary Disease
Coronary Artery Disease
Coronary Restenosis

Interventions

DEVICE: XIENCE V® Everolimus Eluting Coronary Stent System (EECSS)

Sponsor

Abbott Medical Devices